BLT 0.00% 10.5¢ benitec biopharma limited

Hep C market - regulus results

  1. 233 Posts.
    lightbulb Created with Sketch. 38
    If you listen to the recent video from regulus CEO (who recently sold a majority of his shares) he uses much of the language peter French does about being a game changing tech. Although I don't see regulus currently being much of a shift from current therapies since they want to couple it with antivirals as well.

    They also experience some minor effects and experienced two relapses.

    Be interested in others thoughts
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.